This protocol is judged by an institutional critique board, an impartial group that assessments any clinical trials involving humans. If a review involves a Program I drug, after the board approves the protocol as ethical, the researchers should apply for an investigational new drug (IND) amount from your FDA.Subsequently, medications are sometime